PATHOGENIC FUNGI Medical mycology field of medicine concerned

  • Slides: 124
Download presentation
PATHOGENIC FUNGI

PATHOGENIC FUNGI

Medical mycology • field of medicine concerned with the diagnosis, managements and prevention of

Medical mycology • field of medicine concerned with the diagnosis, managements and prevention of mycoses

MYCOSES • diseases caused by fungi • Mode of infection: – Inhalation – Trauma

MYCOSES • diseases caused by fungi • Mode of infection: – Inhalation – Trauma – Ingestion – Rarely from person to person • Most mycoses are not contagious

Clinical Manifestations of Mycoses • Fungal infections (most common) • Toxicoses (poisoning) • Allergies

Clinical Manifestations of Mycoses • Fungal infections (most common) • Toxicoses (poisoning) • Allergies (hypersensitivity reactions)

DIAGNOSI S

DIAGNOSI S

DIAGNOSIS • Sabourad dextrose agar – the medium where fungi is cultured • Potassium

DIAGNOSIS • Sabourad dextrose agar – the medium where fungi is cultured • Potassium hydroxide (KOH) preparations – dissolve keratin in skin scrapings or biopsy specimens, leaving only fungal cells for examination • Gomori methenamine silver (GMS) stain – used on tissue to stain fungal cells black • Direct immunofluorescence - labeling of antibodies or antigens with fluorescent dyes.

Mycoses are also among the most difficult diseases to heal.

Mycoses are also among the most difficult diseases to heal.

WHY? • Fungi possess the biochemical ability to resist the oxidative damage perpetuated by

WHY? • Fungi possess the biochemical ability to resist the oxidative damage perpetuated by T cells during cell-mediated immune response • Fungi are eukaryotic and thus biochemically similar to human cells, which means most fungicides are toxic to human tissues

The Gold Standard!!! • Amphotericin B – considered the best drug for treating systemic

The Gold Standard!!! • Amphotericin B – considered the best drug for treating systemic mycoses and other fungal infections that do not respond to other drugs

The downside…. . It is still toxic to humans

The downside…. . It is still toxic to humans

The alternative. . • Azole drugs – which only inhibit the fungi (fungistatic) rather

The alternative. . • Azole drugs – which only inhibit the fungi (fungistatic) rather than kill it – less toxic to humans – e. g. ketoconazole, itraconazole and fluconazole

Categories of Fungal Agents • True fungal pathogens • Opportunistic fungi

Categories of Fungal Agents • True fungal pathogens • Opportunistic fungi

True pathogens • Have the ability to actively attack and invade tissues • Can

True pathogens • Have the ability to actively attack and invade tissues • Can infect any host, regardless of its immune status

Opportunistic Fungi • Lack genes for proteins that aid in colonizing the body •

Opportunistic Fungi • Lack genes for proteins that aid in colonizing the body • Do not cause disease in healthy individuals • Can infect only susceptible individuals, those whose body’s defenses are low

The only fungi known to cause disease in humans: • • Blastomyces dermatiditis Coccidiodes

The only fungi known to cause disease in humans: • • Blastomyces dermatiditis Coccidiodes immitis Histoplasma capsulatum Paracoccidiodes brasiliensis The remaining fungi that cause disease are considered opportunistic fungi.

The following slides may contain scenes not suitable for very young audiences. Those with

The following slides may contain scenes not suitable for very young audiences. Those with weak constitutions are asked to continue paying attention no matter how utterly repulsive you may find it to be. VIEWER’S DISCRETION IS ADVISED.

SYSTEMIC MYCOSIS caused by TRUE PATHOGENS

SYSTEMIC MYCOSIS caused by TRUE PATHOGENS

SYSTEMIC MYCOSES • those fungal infections that spread throughout the body • result of

SYSTEMIC MYCOSES • those fungal infections that spread throughout the body • result of infections by one of the four pathogenic, dimorphic fungi of the division Ascomycota. • Ascomycota: Blastomyces, Coccidioides, Histoplasma, and Paracocidioides

BLASTOMYCOSI S

BLASTOMYCOSI S

BLASTOMYCOSIS • Pathogen: Blastomyces dermatitidis. • B. dermatitidis normally grows in soil rich in

BLASTOMYCOSIS • Pathogen: Blastomyces dermatitidis. • B. dermatitidis normally grows in soil rich in organic material, such as decaying vegetation and animal wastes, where cool, damp conditions favor growth and sporulation.

BLASTOMYCOSIS • Mode of infection: Inhalation of dust disturbed from the environmental sources carries

BLASTOMYCOSIS • Mode of infection: Inhalation of dust disturbed from the environmental sources carries fungal spores and pieces of hyphae into the lungs.

BLASTOMYCOSIS • Pulmonary Blastomycosis – the most common manifestation of Blastomyces infection in humans.

BLASTOMYCOSIS • Pulmonary Blastomycosis – the most common manifestation of Blastomyces infection in humans. • Initial pulmonary lesions are asymptomatic. • If symptoms do develop, they are vague and include cough, fever, malaise, and weight loss.

BLASTOMYCOSIS • Cutaneous blastomycosis – consists of generally painless lesions on the face and

BLASTOMYCOSIS • Cutaneous blastomycosis – consists of generally painless lesions on the face and upper body. • Can be raised and wartlike, craterlike due to the death of tissue.

BLASTOMYCOSIS • Osteoarticular blastomycosis – a condition where fungus spreads to the spine, pelvis,

BLASTOMYCOSIS • Osteoarticular blastomycosis – a condition where fungus spreads to the spine, pelvis, cranium, ribs, long bones, or subcutaneous tissues surrounding joints.

 • Patients with Cutaneous blastomycosis • painless lesions on the face and upper

• Patients with Cutaneous blastomycosis • painless lesions on the face and upper body.

BLASTOMYCOSIS • Diagnosis – relies on identification of B. dermatitis following culture, or direct

BLASTOMYCOSIS • Diagnosis – relies on identification of B. dermatitis following culture, or direct examination of various samples such as sputum, bronchial washings, biopsies, cerebrospinal fluid, or skin scrapings. • Treatment – amphotericin for 10 weeks.

COCCIDIOIDOMYCOSI S

COCCIDIOIDOMYCOSI S

COCCIDIOIDOMYCOSIS Pathogen: Coccidioides immitis • Can be recovered from desert soil, rodent burrows, archaeological

COCCIDIOIDOMYCOSIS Pathogen: Coccidioides immitis • Can be recovered from desert soil, rodent burrows, archaeological remains, and mines. • Once inhaled in dust, anthrospores become trapped in the alveolar spaces of the lungs.

COCCIDIOIDOMYCOSIS • Major manifestation - pulmonary • Invasion of the CNS may result in

COCCIDIOIDOMYCOSIS • Major manifestation - pulmonary • Invasion of the CNS may result in meningitis, headache, nausea, and emotional disturbance

COCCIDIOIDOMYCOSIS • Diagnosis – based on the identification of spherules in KOH- or GMS-

COCCIDIOIDOMYCOSIS • Diagnosis – based on the identification of spherules in KOH- or GMS- treated samples collected from patients • Amphotericin B – the drug of choice

HISTOPLASMOSI S

HISTOPLASMOSI S

HISTOPLASMOSIS • Pathogen: Histoplasma capsulatum • most common fungal pathogen affecting humans. • Two

HISTOPLASMOSIS • Pathogen: Histoplasma capsulatum • most common fungal pathogen affecting humans. • Two strains recognized: a. strain capsulatum - intracellular parasite, first attacks alveolar macrophages in lungs b. strain duboisii - limited to Africa.

HISTOPLASMOSIS • Diagnosis – based on the identification of the distinctive budding yeast in

HISTOPLASMOSIS • Diagnosis – based on the identification of the distinctive budding yeast in KOH- or GMS - prepared samples of skin scrapings, sputum, cerebrospinal fluid, or various tissues.

Lungs of normal person and a patient with histoplasmosis

Lungs of normal person and a patient with histoplasmosis

HISTOPLASMOSIS TREATMENT: • Amphotericin B - prescribed when symptoms do not resolve. • Ketoconazole

HISTOPLASMOSIS TREATMENT: • Amphotericin B - prescribed when symptoms do not resolve. • Ketoconazole – used to treat mild infections.

PARACOCCIDIOIDOMYCOSI S

PARACOCCIDIOIDOMYCOSI S

PARACOCCIDIOIDOMYCOSIS • Pathogen: Paracoccidioides brasiliensis • chronic granulomatous disease that characteristically produces a primary

PARACOCCIDIOIDOMYCOSIS • Pathogen: Paracoccidioides brasiliensis • chronic granulomatous disease that characteristically produces a primary pulmonary infection, and then disseminates to form ulcerative granulomata of the buccal, nasal and occasionally the gastrointestinal mucosa.

Paracoccidiomycosis patients – ulcerative granulomata of the buccal, nasal mucosa…

Paracoccidiomycosis patients – ulcerative granulomata of the buccal, nasal mucosa…

PARACOCCIDIOIDOMYCOSIS • Diagnosis - KOH or GMS preparations of tissue samples revealing yeast cells

PARACOCCIDIOIDOMYCOSIS • Diagnosis - KOH or GMS preparations of tissue samples revealing yeast cells with multiple buds in a “steering wheel” formation. Steering wheel apperance

PARACOCCIDIOIDOMYCOSIS • Treatment - Amphotericin B or Ketoconazole

PARACOCCIDIOIDOMYCOSIS • Treatment - Amphotericin B or Ketoconazole

End of slideshow, click to exit. Aww… sorry, wrong number. .

End of slideshow, click to exit. Aww… sorry, wrong number. .

Systemic Mycoses caused by OPPORTUNISTIC FUNGI

Systemic Mycoses caused by OPPORTUNISTIC FUNGI

Systemic Mycoses Caused by Opportunistic Fungi • Opportunistic mycoses do not typically affect health

Systemic Mycoses Caused by Opportunistic Fungi • Opportunistic mycoses do not typically affect health humans. • One of the more significant causes of human disease and death and appear only when their hosts are weakened. • considered “classical” opportunists because they are routinely encountered.

 • 5 genera of opportunistic fungi that cause systemic mycoses: – Aspergillus –

• 5 genera of opportunistic fungi that cause systemic mycoses: – Aspergillus – Candida – Cryptococcus – Pneumocystis – and Mucor

ASPERGILLOSI S

ASPERGILLOSI S

ASPERGILLOSI S • Pathogens: Aspergillus fumigatus Aspergillus niger and Aspergillus flavus • a term

ASPERGILLOSI S • Pathogens: Aspergillus fumigatus Aspergillus niger and Aspergillus flavus • a term for several diseases caused by the inhalation of spores of fungi • causes allergies and a growing problem for AIDS patients. This an asparagus. . Not an Aspergillus!

ASPERGILLOSI S • 3 clinical manifestations: -Hypertensitivity aspergillosismanifests as asthma -Noninvasive aspergillomas- ballmasses of

ASPERGILLOSI S • 3 clinical manifestations: -Hypertensitivity aspergillosismanifests as asthma -Noninvasive aspergillomas- ballmasses of fungal hyphae like

ASPERGILLOSI S - Acute invasive pulmonary aspergillosismore serious. Signs and symptoms, which include fever,

ASPERGILLOSI S - Acute invasive pulmonary aspergillosismore serious. Signs and symptoms, which include fever, cough, and pain, may present as mild pneumonia.

Aspergillus growing inside the lungs of a bird

Aspergillus growing inside the lungs of a bird

ASPERGILLOSI S • TREATMENT of hypersensitivity - either the use of various allergy medications

ASPERGILLOSI S • TREATMENT of hypersensitivity - either the use of various allergy medications or desensitization to the allergen. • Invasive disease – treated by surgical removal of aspergillomas and surrounding tissue, plus high-dose, intravenous administration of amphotericin B.

CANDIDIASI S

CANDIDIASI S

CANDIDIASIS • Pathogen: Candida albicans. • Common members of the microbiota of the skin

CANDIDIASIS • Pathogen: Candida albicans. • Common members of the microbiota of the skin and mucous membranes.

CANDIDIASIS • Diagnosis – KOH and GMS preparations of skin samples, nail scrapings, cerebrospinal

CANDIDIASIS • Diagnosis – KOH and GMS preparations of skin samples, nail scrapings, cerebrospinal fluid, serum, urine, sputum, or tissue biopsies can reveal clusters of budding yeast and branching pseudohyphae.

CANDIDIASIS l TREATMENT – Nystatin for oral candidiasis in infants. l Amphotericin B-treatment for

CANDIDIASIS l TREATMENT – Nystatin for oral candidiasis in infants. l Amphotericin B-treatment for invasive candidiasis.

C R Y P T O C C OS I S

C R Y P T O C C OS I S

CRYPTOCOCCOSIS • Pathogen: Cryptococcus neoformans • Human infections result from the inhalation of spores

CRYPTOCOCCOSIS • Pathogen: Cryptococcus neoformans • Human infections result from the inhalation of spores and/or dried yeast forms made airborne. • Cryptococcal meningitis – most common clinical form of cryptococcal infection, follows dissemination of the fungus to the CNS.

CRYPTOCOCCOSIS • Diagnosis – involves collecting specimen samples that correlate with the symptoms.

CRYPTOCOCCOSIS • Diagnosis – involves collecting specimen samples that correlate with the symptoms.

CRYPTOCOCCOSIS • Treatment – Amphotericin B and 5 fluorocytosine administered together for 6 -10

CRYPTOCOCCOSIS • Treatment – Amphotericin B and 5 fluorocytosine administered together for 6 -10 weeks.

PNEUMOCYSTIS PNEUMONIA

PNEUMOCYSTIS PNEUMONIA

PNEUMOCYSTIS PNEUMONIA • Pathogen: Pneumocystis jiroveci • Originally considered a protozoan but has been

PNEUMOCYSTIS PNEUMONIA • Pathogen: Pneumocystis jiroveci • Originally considered a protozoan but has been reclassified as a fungus. • An obligate parasite and cannot survive on its own.

PNEUMOCYSTIS PNEUMONIA l Transmission occurs through inhalation of droplet nuclei containing fungus. l DIAGNOSIS

PNEUMOCYSTIS PNEUMONIA l Transmission occurs through inhalation of droplet nuclei containing fungus. l DIAGNOSIS – relies on clinical and microscopic findings. Chest X-rays usually reveal abnormal lung features. l Treatment- antiprotozoan drugs trimethoprim and sulfanilamide.

ZYGOMYCOSES

ZYGOMYCOSES

ZYGOMYCOSES • are opportunistic fungal infections caused by various genera of fungi, Mucor, Rhizopus,

ZYGOMYCOSES • are opportunistic fungal infections caused by various genera of fungi, Mucor, Rhizopus, and Absisia. • Commonly seen in patients with uncontrolled diabetes, people who inject illegal drugs, in some cancer patients, and in some patients receiving antimicrobial agents. • Infections generally develop in the face and head are.

ZYGOMYCOSES l Conditions which resulted from the dissemination of the infections throughout the body

ZYGOMYCOSES l Conditions which resulted from the dissemination of the infections throughout the body in severely immunocompromised individuals: a. Rhinocerebral zygomycosis b. Pulmonary zygomycosis c. Gastrointestinal zygomycosis d. Cutaneous zygomycosis

Rhinocerebral zygomycosis

Rhinocerebral zygomycosis

ZYGOMYCOSES • DIAGNOSIS – clinically based on patient history and microscopic findings in fungus.

ZYGOMYCOSES • DIAGNOSIS – clinically based on patient history and microscopic findings in fungus. • TREATMENT- physical removal of infected tissues and management of predisposing factors. • Drug of choice- Amphotericin B administered intravenously for 8 -10 weeks.

End of slideshow, click to exit. Di pa-reportun si KATSUS! Nyahahaha! Aw. . Cge

End of slideshow, click to exit. Di pa-reportun si KATSUS! Nyahahaha! Aw. . Cge nlng….

Superficial, Cutaneous, and Subcutaneous Mycoses caused by OPPORTUNISTIC FUNGI

Superficial, Cutaneous, and Subcutaneous Mycoses caused by OPPORTUNISTIC FUNGI

Superficial Mycoses • Usually acquired by direct contact with the fungus and are the

Superficial Mycoses • Usually acquired by direct contact with the fungus and are the most common infections. • Confined at the outer, dead layers of the skin, nails, or hair, all of which are composed of dead cells filled with a protein called keratin.

Superficial Mycoses l Piedra- a superficial infection that forms nodules on hair shafts -

Superficial Mycoses l Piedra- a superficial infection that forms nodules on hair shafts - infections are normally associated with the scalp, but faial and pubic hairs can also be infected -transmission is via shared hair brushes and combs, and several members of a family are typically infected at the same time

Superficial Mycoses l Black piedra- caused by Piedra Hortae - characterized as hard, black

Superficial Mycoses l Black piedra- caused by Piedra Hortae - characterized as hard, black nodules encircling the hair shafts l White piedra- caused by Trichosporon beigelii - characterized as soft, gray to white nodules on the hair shafts

Black piedra

Black piedra

Dermatophytoses l Infections caused by dermatophytes. l Fungal infection of nails and skin. l

Dermatophytoses l Infections caused by dermatophytes. l Fungal infection of nails and skin. l Infections were previously called ringworms because they resemble a worm lying below the surface of the skin.

Dermatophytoses Result from the fungi that use keratin as a nutrient source and thus

Dermatophytoses Result from the fungi that use keratin as a nutrient source and thus colonize only dead layers of the skin, nails, and hair. l No living tissues are infected. l Caused by various Epidermophyton, Microsporum, Trichophyton species. l

Types of Diseases Caused by Dermatophytes Tinea infections (ringworm) l - Athlete’s foot (Tinea

Types of Diseases Caused by Dermatophytes Tinea infections (ringworm) l - Athlete’s foot (Tinea Pedis) l -jock itch (Tinea cruris) l -yeast infections of the mouth and vagina often caused by Candida species. l

Tinea corporis

Tinea corporis

Treatment l l l -can be treated effectively with topical antifungal agents -Terbinafine -griseofulvin

Treatment l l l -can be treated effectively with topical antifungal agents -Terbinafine -griseofulvin

MALASSEZIA

MALASSEZIA

MALASSEZIA INFECTIONS • -Malassezia furfur is a fungus that infects the skin. Clinical manifestations

MALASSEZIA INFECTIONS • -Malassezia furfur is a fungus that infects the skin. Clinical manifestations include pityriasis, in which fungal growth disrupts melanin production to produce discolored patches, and the most common manifestation of M. furfur infectiondandruff.

MALASSEZIA INFECTIONS • Folliculitis- caused by M. furfur - involves infection of the hair

MALASSEZIA INFECTIONS • Folliculitis- caused by M. furfur - involves infection of the hair follicles on the back, chest, and upper arm, producing follicular papules or pustules

MALASSEZIA INFECTIONS • Diagnosis - examining the patient under ultraviolet illumination, though some other

MALASSEZIA INFECTIONS • Diagnosis - examining the patient under ultraviolet illumination, though some other fungi also fluoresce. • Treatment - solutions of antifungal imidazoles, such as ketoconazole shampoos. - topical applications of zinc pyrithione -selenium sulfide lotions - propylene glycol

Cutaneous and Subcutaneous Mycoses

Cutaneous and Subcutaneous Mycoses

Cutaneous and Subcutaneous Mycoses • Infection requires traumatic introduction of fungal elements beneath the

Cutaneous and Subcutaneous Mycoses • Infection requires traumatic introduction of fungal elements beneath the outer, dead layers of skin.

CHROMOBLASTOMYCOSIS AND PHAEOHYPHOMYCOSIS l Chromoblastomycosis- small, itchy but painless, scaly lesions on the skin

CHROMOBLASTOMYCOSIS AND PHAEOHYPHOMYCOSIS l Chromoblastomycosis- small, itchy but painless, scaly lesions on the skin surface resulting from fungal growth in subcutaneous tissues near the site of inoculation.

PHAEOHYPHOMYCOSIS Paranasal sinus phaeophomycosis – involves colonization of the nasal passages and sinuses; it

PHAEOHYPHOMYCOSIS Paranasal sinus phaeophomycosis – involves colonization of the nasal passages and sinuses; it occurs in allergy sufferers and AIDS patients l Cerebral phaeophomycosis – caused by Cladophiolophora bantiana - has a preference for neural cells and actively invades the brain

Patients with chromoblastomycosis

Patients with chromoblastomycosis

Treatment l Phaeohyphomycosis can be treated with intraconazole, but the disease is permanently destructive

Treatment l Phaeohyphomycosis can be treated with intraconazole, but the disease is permanently destructive to tissues l Chromoblastomycosis requires surgical removal of infected and surrounding tissues followed by antifungal therapy.

MYCETOMAS

MYCETOMAS

MYCETOMAS l - tumorlike infections of the skin, fascia (lining of muscles), and bones

MYCETOMAS l - tumorlike infections of the skin, fascia (lining of muscles), and bones of the hands of feet caused by mycelial fungi l l This fungi live in soil and are introduced into humans via the prick wounds and scrapes caused by twigs, thorns, or leaves contaminated with fungi.

Treatment l l Surgical removal of the mycetoma Anti fungal therapy with ketoconazole

Treatment l l Surgical removal of the mycetoma Anti fungal therapy with ketoconazole

SPOROTRICHOSIS

SPOROTRICHOSIS

SPOROTRICHOSIS l Pathogen: Sporothrix schenckii l Also called “rose-gardener’s disease”, a subcutaneous infection limited

SPOROTRICHOSIS l Pathogen: Sporothrix schenckii l Also called “rose-gardener’s disease”, a subcutaneous infection limited to the arms and legs.

Treatment l l Topical applications of saturated potassium iodide for several months Itraconazole Terbinafine

Treatment l l Topical applications of saturated potassium iodide for several months Itraconazole Terbinafine It can be prevented by wearing of gloves, long clothing and shoes to prevent inoculation.

Summing it all up…

Summing it all up…

CATEGORIES OF FUNGAL AGENTS True Fungal Pathogens Opportunistic Fungi Systemic Mycoses Superficial Mycoses Blastomyces

CATEGORIES OF FUNGAL AGENTS True Fungal Pathogens Opportunistic Fungi Systemic Mycoses Superficial Mycoses Blastomyces Aspergillus Dermatophytes Coccidioides Candida Systemic Mycoses Cryptococcus Histoplasma Pneumocystis Paracoccidioides Mucor Malassezia Cutaneous and Subcutaneous Chromoblastomycosis Phaehyphomycosis mycelial fungi Sporothrix

Going back. . .

Going back. . .

Clinical Manifestations of Mycoses • Fungal infections (most common) • Toxicoses (poisoning) • Allergies

Clinical Manifestations of Mycoses • Fungal infections (most common) • Toxicoses (poisoning) • Allergies (hypersensitivity reactions)

TOXICOSIS

TOXICOSIS

Toxicosis • Mycotoxicosis – caused by eating food contaminated with fungal toxins only •

Toxicosis • Mycotoxicosis – caused by eating food contaminated with fungal toxins only • Mycetismus - poisoning caused by eating the fungus

Mycotoxicosis • Mycotoxins – chemicals produced by fungi during metabolism, that are poisonous to

Mycotoxicosis • Mycotoxins – chemicals produced by fungi during metabolism, that are poisonous to humans • Aflatoxins – are the most well-known mycotoxins, produced by certain species of Aspergillus

Mycetismus • Amanita phalloides – “death cap mushroom” – Produces the deadliest mushroom toxin

Mycetismus • Amanita phalloides – “death cap mushroom” – Produces the deadliest mushroom toxin

Allergies to Fungi • Allergens – spores or other fungal elements that cause type

Allergies to Fungi • Allergens – spores or other fungal elements that cause type I hypersensitivities, or more rarely, type III